The Involvement of the Myelin-Associated Inhibitors and Their Receptors in CNS Plasticity and Injury.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing preclinical mechanisms and clinical trials without systematic methodology
PubMed 28229330 · doi:10.1007/s12035-017-0433-6
What was done
This narrative review synthesized literature on myelin-associated inhibitors (MAIs), their receptors, and downstream effectors in central nervous system (CNS) development, plasticity, and injury. It surveyed preclinical and clinical trial data on therapeutic candidate molecules designed to interfere with MAI signaling to promote neurite outgrowth.
What was found
The abstract reports no numerical data, effect sizes, or study counts. It qualitatively notes that MAIs located on oligodendroglial membranes inhibit neurite outgrowth in the injured adult CNS, and that experimental disruption of these proteins promotes neurite outgrowth and improves functional recovery in CNS injury models.
Why it matters
Understanding and targeting MAI signaling pathways outlines potential therapeutic strategies to overcome intrinsic barriers to axonal regeneration following CNS trauma.
Limits
As a narrative review, it lacks a systematic search protocol, inclusion/exclusion criteria, and formal risk-of-bias evaluation. The abstract reports no quantitative metrics, and findings primarily rely on preclinical animal models that may not directly translate to human clinical efficacy.
Cited by
- supports Peripheral nerves readily regenerate after injury, unlike central nervous system tissue following brain injury.